ATE173476T1 - 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica - Google Patents

1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica

Info

Publication number
ATE173476T1
ATE173476T1 AT91911396T AT91911396T ATE173476T1 AT E173476 T1 ATE173476 T1 AT E173476T1 AT 91911396 T AT91911396 T AT 91911396T AT 91911396 T AT91911396 T AT 91911396T AT E173476 T1 ATE173476 T1 AT E173476T1
Authority
AT
Austria
Prior art keywords
antiarrhythmics
benzoyl
imidazole
piperidine derivatives
agents
Prior art date
Application number
AT91911396T
Other languages
English (en)
Inventor
You-Ling Chou
Paul William Erhardt
Alfred Arthur Hagedorn
John W Lampe
William Carl Lumma Jr
Thomas Kenneth Morgan
Jay Ross Wiggins
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE173476T1 publication Critical patent/ATE173476T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT91911396T 1990-06-20 1991-06-19 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica ATE173476T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,980 US5189036A (en) 1990-06-20 1990-06-20 Imidazolylbenzoyl substituted heterocycles

Publications (1)

Publication Number Publication Date
ATE173476T1 true ATE173476T1 (de) 1998-12-15

Family

ID=24157703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911396T ATE173476T1 (de) 1990-06-20 1991-06-19 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica

Country Status (6)

Country Link
US (1) US5189036A (de)
EP (1) EP0537201B1 (de)
JP (1) JPH05509303A (de)
AT (1) ATE173476T1 (de)
DE (1) DE69130505D1 (de)
WO (1) WO1991019709A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801650A4 (de) * 1994-12-22 1998-05-06 Smithkline Beecham Corp Fibrinogenrezeptor-antagonisten
US5977376A (en) * 1997-07-18 1999-11-02 Rhone-Poulenc Agriculture Limited Herbicidal 2-benzoylcyclohexane-1,3-diones and related compounds
GB2327418A (en) * 1997-07-18 1999-01-27 Rhone Poulenc Agriculture Derivatives of 2-benzoylcyclohexane-1,3-dione
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US7053089B2 (en) 2001-02-23 2006-05-30 Merck & Co., Inc. N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
US7259157B2 (en) 2001-04-03 2007-08-21 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
AR059826A1 (es) * 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
TW200825072A (en) * 2006-10-20 2008-06-16 Arete Therapeutics Inc Soluble epoxide hydrolase inhibitors
EP2081898A2 (de) * 2006-10-20 2009-07-29 Arete Therapeutics, INC. Adamantylharnstoff-verbindungen als lösliche epoxid-hydrolase-hemmer
TW200837055A (en) * 2007-03-13 2008-09-16 Arete Therapeutics Inc Soluble epoxide hydrolase inhibitors
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
SG175896A1 (en) 2009-05-06 2011-12-29 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804662A (en) * 1987-05-05 1989-02-14 Schering A.G. Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US4868194A (en) * 1988-09-23 1989-09-19 Merrell Dow Pharmaceuticals Inc. Imidazole antiarrhythmics

Also Published As

Publication number Publication date
EP0537201B1 (de) 1998-11-18
EP0537201A1 (de) 1993-04-21
US5189036A (en) 1993-02-23
WO1991019709A1 (en) 1991-12-26
DE69130505D1 (de) 1998-12-24
JPH05509303A (ja) 1993-12-22

Similar Documents

Publication Publication Date Title
ATE173476T1 (de) 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica
US5614543B1 (en) 1-(Aryloxyalkyl)-3-(heteroaryl) pyrrolidines and related compounds useful as antipsychotics and anagesics
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
DE69226953D1 (de) Verwendung von tetrahydrocarbazolderivaten als 5ht1-rezeptor-agonisten
DE69628804D1 (de) Substitutierte heterozyclische Derivate als CRF Antagonisten
DK394589A (da) 3-heterocyclyl-2-phenyl-1-(1h-1,2,4-triazol-1-yl)-alkan-2-ol-forbindelser, deres anvendelse til fremstilling af antifungale midler, farmaceutiske praeparater indeholdende forbindelserne og mellemprodukter ved fremstilling af forbindelserne
ATE131820T1 (de) Azole als pestizide
ES8505364A1 (es) Un procedimiento para la preparacion 1-imidazoles y 1h-1, 2, 4-triazoles
ATE157089T1 (de) Derivate von alkanolaminen als kardiovaskuläre mittel
NO924598L (no) Fremstilling av substituerte piperidiner
ATE102191T1 (de) Substituierte 4-(1h-imidazol-1-yl>benzamide als antiarrhythmische mittel.
DE59200199D1 (de) Fungizide Mischung.
NO900019L (no) Piperidiner og fremgangsmaate til fremstilling derav.
ATE116316T1 (de) Antipsychotische 4-(1,2- benzisoazolyl)piperidinderivate.
DK0439265T3 (da) Hidtil ukendte 1,3-dicarbonylforbindelser og anvendelse deraf
DK686088D0 (da) 2-phenyl-3-(piperazin-1-yl)-1-(1h-1,2,4-triazol-1-yl) propan-2-ol-forbindelser
ITMI931685A0 (it) Nuovi derivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici
DE69100517D1 (de) Polyethyleneiminphosphonatderivate als Dispergiermittel enthaltende Zementzusammensetzungen.
IT8921380A0 (it) Composti piperazin piperidinici atti all'impiego come stabilizzanti per materiali organici.
FI915056A7 (fi) Substituoidut 1-(alkoksi-iminoalkyyli)imidatsoli-johdannaiset
ATE130162T1 (de) Fungizide wirkstoffkombinationen.
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
NO173866C (no) Mellomprodukter for fremstilling av((4-(4-(4fenyl-1-piperazinyl)fenoskymetyl)-1,3-dioksolan-2-yl)-m etyl)-1h-imidazoler og 1h-1,2,4-triazoler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties